Noetic Fund: A venture fund investing in global mental health, CNS therapeutics, biotech, and wellness.
Location
Toronto, Ontario, CA
Founded
2020
Noetic Fund is a venture capital firm focused on global mental health solutions. They invest primarily in Central Nervous System (CNS) therapeutics, biotech, medtech, pharmaceutical companies, and wellness startups. The fund typically participates in Seed, Series A, and Convertible Note rounds.
Notable portfolio companies include Delix Therapeutics, Gilgamesh Pharmaceuticals, and CaaMTech. Sa'ad Shah, a key partner at Noetic Fund, is known for his expertise in entheogens and psyche-related topics. The firm's investment philosophy centers on advancing innovative solutions in mental health and wellness sectors.
Noetic Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies6
Current Portfolio Count6
Top Investment Stages
Series A5 (83.3%)
Seed1 (16.7%)
Stage Mix
Series A 83%Seed 17%
Concentration shown as share of disclosed investments by stage.